Which of the following least likely to cause increase in bradykinin production?
**Core Concept**
The renin-angiotensin-aldosterone system (RAAS) and the kallikrein-kinin system (KKS) are two closely related pathways that regulate blood pressure and electrolyte balance. The KKS, particularly the conversion of kininogen to bradykinin by kallikrein, plays a crucial role in vasodilation and sodium excretion.
**Why the Correct Answer is Right**
Bradykinin is a potent vasodilator that increases sodium excretion and lowers blood pressure. Its production is primarily facilitated by the kallikrein-kinin system. In contrast, the RAAS, which involves the conversion of angiotensinogen to angiotensin II by renin, is a vasoconstrictor that increases blood pressure and sodium retention. The RAAS and KKS have opposing effects on blood pressure regulation.
**Why Each Wrong Option is Incorrect**
* **Option A:** Angiotensin-converting enzyme (ACE) inhibitors, which block the conversion of angiotensin I to angiotensin II, can actually increase bradykinin levels by reducing the breakdown of bradykinin by ACE.
* **Option B:** Angiotensin II, the primary effector molecule of the RAAS, can stimulate the release of aldosterone, which promotes sodium retention and increases blood pressure. However, it does not directly increase bradykinin production.
* **Option D:** The direct renin inhibitors, which block the conversion of angiotensinogen to angiotensin I by renin, can also lead to increased bradykinin levels due to reduced breakdown of bradykinin by ACE.
**Clinical Pearl / High-Yield Fact**
It is essential to remember that ACE inhibitors and direct renin inhibitors can increase bradykinin levels, leading to potential side effects such as cough and angioedema.
**Correct Answer: B. Angiotensin II**